Medtronic (NYSE: MDT) reported Q4 EPS of $1.55, $0.01 better than the analyst estimate of $1.54. Revenue for the quarter came in at $9.8 billion versus the consensus estimate of $9.63 billion.

GUIDANCE:

Medtronic sees FY2027 EPS of $5.90-$6.00, versus the consensus of $6.06.

For earnings history and earnings-related data on Medtronic (MDT) click here.